Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT06917261
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years of age
* Consulting or hospitalized at the University Hospital of Grenoble Alpes, for whom a SARS-CoV-2 RT-PCR test via nasal swab is considered due to symptoms or context (hospitalization in a double room, ongoing epidemic outbreak)
* Having provided informed consent to participate in the study.
* Patient having the rights to French social insurance
Exclusion Criteria:
* Contraindication to nasopharyngeal swabbing:
* Anatomical abnormalities or medical conditions:
* Severe nasal septum deviation or nasal polyps
* History of recent nasal or facial surgery
* Severe sinusitis or nasal infections
* Bleeding disorders
* Extreme sensitivity or phobias related to medical procedures
* Participation in an exclusion period of another SARS-CoV-2 performance study: Minors
Pregnant or breastfeeding women, Individuals under guardianship or curatorship, Individuals deprived of liberty or involuntarily hospitalized, Individuals under administrative or judicial supervision, Persons unable to provide informed consent
* Staff with a hierarchical relationship with the principal investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06917261
Study Brief:
Protocol Section:
NCT06917261